Recent Updates
Recently added Catalysts
FTRE Positive Sentiment Score: 75/100

Fortrea to Present at the Jefferies Global Healthcare Conference

Key Takeaway: Fortrea, a prominent global contract research organization, will present at the Jefferies Global Healthcare Conference on June 5, 2025. The presentation will be led by Chairman Peter M. Neupert and CFO Jill McConnell. Investors can access the live webcast on the company's Investor Relations website, with a replay available afterward.
Price reaction · baseline $17.06 (2026-01-26 close) · hit pre-market · 1 other FTRE headline(s) in the window, move may be shared
day 0 close · peak
+0.4%

Conference Participation Details

Jefferies Global Healthcare Conference
Date: November 18, 2025
Time: 11:30 a.m. GMT / 6:30 a.m. ET
Location: London
Format: Fireside Chat

How to Access

Investors and the general public can listen to both sessions live at:

https://investor.viatris.com

Archived versions will be available following the live events for a limited time.

Market Sentiment Analysis

POSITIVE FACTORS

  • Fortrea is actively engaging with investors at a major healthcare conference.
  • The company showcases its leadership and commitment to healthcare innovation.
  • The webcast allows broader access to Fortrea's updates and insights.

Full Press Release Details

DURHAM, N.C., June 03, 2025 (GLOBE NEWSWIRE) --Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced that Chairman and Interim Chief Executive Officer, Peter M. Neupert and Chief Financial Officer, Jill McConnell will present at the Jefferies Global Healthcare Conference on Thursday, June 5, 2025 at 8:45 am ET.
The live webcast will be available to investors and other interested parties by accessing the FortreaInvestor Relations website. A webcast replay will be available after the event.

About Fortrea

Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, biotechnology, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients. Fortrea provides phase I-IV clinical trial management, clinical pharmacology and consulting services. Fortrea’s solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, exceptional insights and a strong investigator site network. Our talented and diverse team working in about 100 countries is scaled to deliver focused and agile solutions to customers globally. Learn more about how Fortrea is becoming a transformative force from pipeline to patient atFortrea.comand follow us onLinkedInandX(formerly Twitter).

Fortrea Contacts:

Hima Inguva (Investors) – 877-495-0816,hima.inguva@fortrea.comSue Zaranek (Media) – 919-943-5422,media@fortrea.comKate Dillon (Media) – 646-818-9115,kdillon@prosek.com

Frequently Asked Questions

When is Fortrea presenting at the Jefferies Conference?

Fortrea will present on June 5, 2025, at 8:45 am ET.

Who will represent Fortrea at the conference?

Chairman Peter M. Neupert and CFO Jill McConnell will present.

How can I access the presentation?

The presentation will be available via a live webcast on Fortrea's Investor Relations website.

Will there be a replay of the presentation?

Yes, a replay of the webcast will be available after the event.

Last updated: Jan 27, 2026